Hla T - Search Results

1

Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs.

Hida T, Leyton J, Makheja AN, Ben-Av P, Hla T, Martinez A, Mulshine J, Malkani S, Chung P, Moody TW. Hida T, et al. Among authors: hla t. Anticancer Res. 1998 Mar-Apr;18(2A):775-82. Anticancer Res. 1998. PMID: 9615719

2

Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells.

Casibang M, Purdom S, Jakowlew S, Neckers L, Zia F, Ben-Av P, Hla T, You L, Jablons DM, Moody TW. Casibang M, et al. Among authors: hla t. Lung Cancer. 2001 Feb-Mar;31(2-3):203-12. doi: 10.1016/s0169-5002(00)00168-9. Lung Cancer. 2001. PMID: 11165399

3

Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis.

Ben-Av P, Crofford LJ, Wilder RL, Hla T. Ben-Av P, et al. Among authors: hla t. FEBS Lett. 1995 Sep 18;372(1):83-7. doi: 10.1016/0014-5793(95)00956-a. FEBS Lett. 1995. PMID: 7556649 Free article.

4

Dissociation of basal turnover and cytokine-induced transcript stabilization of the human cyclooxygenase-2 mRNA by mutagenesis of the 3'-untranslated region.

Gou Q, Liu CH, Ben-Av P, Hla T. Gou Q, et al. Among authors: hla t. Biochem Biophys Res Commun. 1998 Jan 26;242(3):508-12. doi: 10.1006/bbrc.1997.7994. Biochem Biophys Res Commun. 1998. PMID: 9464246

5

The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia.

Chang SH, Ai Y, Breyer RM, Lane TF, Hla T. Chang SH, et al. Among authors: hla t. Cancer Res. 2005 Jun 1;65(11):4496-9. doi: 10.1158/0008-5472.CAN-05-0129. Cancer Res. 2005. PMID: 15930264

6

Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.

Chang SH, Liu CH, Conway R, Han DK, Nithipatikom K, Trifan OC, Lane TF, Hla T. Chang SH, et al. Among authors: hla t. Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):591-6. doi: 10.1073/pnas.2535911100. Epub 2003 Dec 19. Proc Natl Acad Sci U S A. 2004. PMID: 14688410 Free PMC article.

7

Human cyclooxygenase-2 cDNA.

Hla T, Neilson K. Hla T, et al. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7384-8. doi: 10.1073/pnas.89.16.7384. Proc Natl Acad Sci U S A. 1992. PMID: 1380156 Free PMC article.

8

Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation.

Ristimäki A, Garfinkel S, Wessendorf J, Maciag T, Hla T. Ristimäki A, et al. Among authors: hla t. J Biol Chem. 1994 Apr 22;269(16):11769-75. J Biol Chem. 1994. PMID: 8163473 Free article.

9

COX-2 inhibitors and genetic background reduce mammary tumorigenesis in cyclooxygenase-2 transgenic mice.

Narko K, Zweifel B, Trifan O, Ristimäki A, Lane TF, Hla T. Narko K, et al. Among authors: hla t. Prostaglandins Other Lipid Mediat. 2005 May;76(1-4):86-94. doi: 10.1016/j.prostaglandins.2005.01.002. Prostaglandins Other Lipid Mediat. 2005. PMID: 15967164

10

Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation.

Ristimäki A, Narko K, Hla T. Ristimäki A, et al. Among authors: hla t. Biochem J. 1996 Aug 15;318 ( Pt 1)(Pt 1):325-31. doi: 10.1042/bj3180325. Biochem J. 1996. PMID: 8761489 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters